- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20:10 | Geron to lay off third of workforce in bid to slash operating costs | 1 | FiercePharma | ||
| 20:10 | Ovid Therapeutics: Aktionäre genehmigen Erhöhung der genehmigten Aktien und weitere Anträge | 2 | Investing.com Deutsch | ||
| 20:10 | Enveric Biosciences sichert sich 3,1 Mio. US-Dollar durch Ausübung von Optionsscheinen | 1 | Investing.com Deutsch | ||
| 19:58 | Morgan Stanley hebt Kursziel für Rhythm Pharmaceuticals auf 150 $ an | 3 | Investing.com Deutsch | ||
| 19:54 | Morgan Stanley raises Rhythm Pharmaceuticals stock price target to $150 | 1 | Investing.com | ||
| 19:54 | Enveric Biosciences secures $3.1 million through warrant exercise | 1 | Investing.com | ||
| 19:48 | Poxel SA: Poxel Announces Results of its Combined General Meeting Held on December 11, 2025 | 132 | Business Wire | Regulatory News:
POXEL SA (Euronext: POXEL FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology... ► Artikel lesen | |
| 19:42 | Roivant Signals Major Pipeline Momentum With Accelerated Timelines | 5 | Benzinga.com | ||
| 19:34 | BTIG senkt Kursziel für Rezolute nach Studienfehlschlag auf 5,00 $ | 13 | Investing.com Deutsch | ||
| 19:34 | Raymond James bestätigt Aardvark Therapeutics mit "Strong Buy" und Kursziel von 47 $ | 2 | Investing.com Deutsch | ||
| 19:31 | Why I Wouldn't Touch Novavax With a 10-Foot Pole | 2 | The Motley Fool | ||
| 19:30 | Rezolute stock price target cut to $5 from $17 at BTIG after trial failure | 1 | Investing.com | ||
| 19:30 | Raymond James reiterates Strong Buy on Aardvark Therapeutics stock with $47 target | 4 | Investing.com | ||
| 19:26 | Citi Asserts Buy Rating on Summit Therapeutics Inc. (SMMT) on Pipeline Development | 2 | Insider Monkey | ||
| 19:26 | This is why Viking Therapeutics, Inc. (VKTX) is a Strong Buy on Wall Street | 1 | Insider Monkey | ||
| 19:26 | Legend Biotech Corporation (LEGN) is an Outperform on Multiple Myeloma Treatment CARVYKTI Prospects | 2 | Insider Monkey | ||
| 19:26 | Vaxcyte, Inc. (PCVX) Makes Strides on Pneumonia Treatment, Plots Coverage Extension | 2 | Insider Monkey | ||
| 19:18 | Why Is XOMA Royalty Stock Sinking Thursday? | 2 | Benzinga.com | ||
| 19:18 | Rhythm Pharma Strikes Chord As Early PWS Trial Results Show Promise | 2 | Benzinga.com | ||
| 19:10 | Aktionäre von Enveric Biosciences genehmigen Aktienausgabe und Kapitalerhöhung | 1 | Investing.com Deutsch |
1 2 3 4 5 Weiter >>
- 24 h
- 7 Tage
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| EVOTEC | 13 | 44 | -0,04 % | DAX-Check LIVE: Aurubis, Evotec, Formycon, Infineon, Porsche SE, Siemens Energy im Fokus | Die Erholung an der Börse hat sich zur Wochenmitte nicht fortgesetzt. Der DAX startete zwar mit kleinen Gewinnen in den Tag, rutschte im Verlauf jedoch ins Minus und schloss schließlich bei 23.694 Punkten... ► Artikel lesen | ||
| BIONTECH | 9 | 13 | -0,43 % | Arrowhead, BioNTech, Madrigal & Co: Biotech-Power für das Depot! | Das Börsenjahr 2025 stand natürlich ganz klar im Schatten der US-Technologieriesen wie Nvidia & Co. Darüber hinaus sorgten auch die Gold- und Silberaktien für Aufsehen, doch eine stark laufende Branche... ► Artikel lesen | ||
| AC IMMUNE | 8 | - | +13,00 % | XFRA IMR: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILAC IMMUNE SA SF-... ► Artikel lesen | ||
| GRI BIO | 7 | - | -54,36 % | GRI Bio, Inc.: GRI Bio Announces Positive Topline Data from its Phase 2a Study in Idiopathic Pulmonary Fibrosis ("IPF") | Study met its primary endpoint demonstrating that GRI-0621 was well tolerated over 12 weeks of treatment, with no drug-related severe or serious adverse events and no increase in GI issues when used... ► Artikel lesen | ||
| REZOLUTE | 7 | - | -87,02 % | Xoma Crumbles And Partner Rezolute Collapses On Failed Insulin Disease Drug | |||
| KYMERA THERAPEUTICS | 6 | 6 | -2,31 % | Kymera Therapeutics, Inc.: Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Atopic Dermatitis | Fast Track designation supported by positive results from the KT-621 BroADen Phase 1b atopic dermatitis (AD) patient trial KT-621 BROADEN2 Phase 2b AD trial ongoing, with data expected to be reported... ► Artikel lesen | ||
| RHYTHM PHARMACEUTICALS | 6 | 3 | +13,97 % | Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals Announces Preliminary Data from Exploratory Phase 2 Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome | - - BMI and hyperphagia reductions have been observed in patients with PWS treated with setmelanotide at Month 3 (n=8) and Month 6 (n=5); 17 of 18 enrolled patients remain on therapy -- -- Promising... ► Artikel lesen | ||
| MODERNA | 5 | 16 | +0,93 % | Nanexa AB: Nanexa and Moderna enter into license and option agreement for the development of PharmaShell-based products | The agreement covers the development of up to five undisclosed compounds. Nanexa will receive an upfront payment of USD 3 million and is entitled to up to USD 500 million in potential milestone payments... ► Artikel lesen | ||
| XOMA ROYALTY | 5 | 2 | -22,97 % | XOMA Royalty Corporation: XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc | EMERYVILLE, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation ("XOMA Royalty") (Nasdaq: XOMA), the biotech royalty aggregator, today announced it has successfully completed its previously... ► Artikel lesen | ||
| VALNEVA | 4 | 5 | +0,16 % | Rheinmetall Aktie: Heiß! - Dt. Börse, Heidelberger Druck, Mutares, Steyr und Valneva im Marktbericht Börse Frankfurt | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen |
- Alle
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| BIO-GATE AG | 0,820 | 3 | +266 % | 1 | 1 | - | |||
| NANOREPRO AG | 1,535 | 4,50 | +193 % | 1 | - | - | |||
| MARINOMED BIOTECH AG | 19,000 | 51 | +168 % | 1 | - | - | |||
| EVOTEC SE | 5,240 | 8 | +53 % | 2 | 2 | - | |||
| BIONTECH SE ADR | 81,55 | 121,08 | +48 % | 6 | 1 | - | |||
| QIAGEN NV | 38,605 | 46 | +19 % | 7 | 1 | - | |||
| SARTORIUS STEDIM BIOTECH SA | 208,00 | 237,50 | +14 % | 6 | 1 | - |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .